Department of Gastroenterology, Türkiye Yüksek İhtisas Education and Research Hospital, Ankara, Turkey.
Surg Endosc. 2021 Aug;35(8):4222-4230. doi: 10.1007/s00464-020-07904-x. Epub 2020 Aug 28.
BACKGROUND/AIM: Endoscopic retrograde cholangiopancreatography (ERCP) in patients with Billroth II gastrectomy is a difficult procedure. Although different endoscopes are used in these patients, comparative studies are limited. The aim of this study was to assess the efficacy and the safety of the forward-viewing gastroscope compared with the side-viewing duodenoscope.
This study was conducted on 75 Billroth II gastrectomy patients who underwent ERCP by the same experienced endoscopist. Procedures were performed using side-viewing duodenoscope in the first 41 patients and forward-viewing gastroscope in the subsequent 34 patients. The success and complication rates of ERCP were compared between the two groups.
Afferent loop intubation was achieved in 39 patients (95.1%) in the side-viewing duodenoscope group and in 34 patients (100%) in the forward-viewing gastroscope group (P = 0.49). The rates of reaching the papilla was 70.7% (n = 29) and 91.1% (n = 31), respectively (P = 0.06). Cannulation success rate after reaching the papilla was 100% in the side-viewing duodenoscope group and 90.3% in the forward-viewing gastroscope group. In the side-viewing duodenoscope group, 11 patients underwent sphincterotomy (EST), 14 patients underwent both EST and endoscopic papillary balloon dilatation (EPBD), and 4 patients underwent only EPBD. All but one patients in the forward-viewing gastroscope group underwent EPBD without EST. The technical and the clinical success rate did not statistically differ between the groups (70.7% vs. 82.3%, 68.3% vs. 79.4%, respectively). Adverse events included jejunal perforation in one patient (2.4%) in the side-viewing duodenoscope group, and pancreatitis in one patient (2.9%) in the forward-viewing gastroscope group (P > 0.05).
This study indicates that forward-viewing gastroscope is as effective as side-viewing duodenoscope for ERCP in patients with Billroth II gastrectomy. Furthermore, EPBD without prior EST appears to be a safe and effective procedure in these patients.
背景/目的:毕罗氏 II 式胃切除术后行内镜逆行胰胆管造影术(ERCP)较为困难。尽管在这些患者中使用了不同的内镜,但相关比较研究有限。本研究旨在评估前视式胃镜与侧视式十二指肠镜的疗效和安全性。
本研究纳入了 75 例由同一位经验丰富的内镜医生行 ERCP 的毕罗氏 II 式胃切除术后患者。前 41 例患者采用侧视式十二指肠镜进行操作,后 34 例患者采用前视式胃镜进行操作。比较两组患者 ERCP 的成功率和并发症发生率。
在侧视式十二指肠镜组中,39 例(95.1%)患者成功插管进入输入袢,前视式胃镜组中 34 例(100%)患者成功插管进入输入袢(P=0.49)。到达乳头的比例分别为 70.7%(n=29)和 91.1%(n=31)(P=0.06)。到达乳头后行乳头切开术的成功率在侧视式十二指肠镜组为 100%,在前视式胃镜组为 90.3%。在侧视式十二指肠镜组中,11 例患者行括约肌切开术(EST),14 例患者行 EST 和内镜乳头气囊扩张术(EPBD),4 例患者仅行 EPBD。在前视式胃镜组中,所有患者均行 EPBD 治疗,无一例行 EST。两组的技术成功率和临床成功率无统计学差异(分别为 70.7% vs. 82.3%,68.3% vs. 79.4%)。不良事件包括侧视式十二指肠镜组 1 例(2.4%)患者发生空肠穿孔,前视式胃镜组 1 例(2.9%)患者发生胰腺炎(P>0.05)。
本研究表明,前视式胃镜用于毕罗氏 II 式胃切除术后患者的 ERCP 与侧视式十二指肠镜同样有效。此外,对于这些患者,在未行 EST 的情况下行 EPBD 似乎是一种安全有效的治疗方法。